Partnership to Advance Precision Diagnostics

Share this post

We are excited to announce our new distribution partnership with Gencurix, Inc. for Germany. They are specialized in molecular cancer diagnostics and offer various ddPCR kits for detecting cancer mutations.

Through this partnership, we aim to advance precision medicine, bringing personalized healthcare solutions to patients in Germany. BIOTYPE and Gencurix will combine their expertise, resources, and networks to introduce state-of-the-art molecular diagnostic solutions to healthcare providers, researchers, and pharmaceutical companies. Together, we will empower physicians with actionable insights, enable targeted therapies, and accelerate the development of groundbreaking treatments.

We welcome Gencurix’s ddPCR tests to our portfolio and look forward to working closely together. Our commitment to providing the highest quality diagnostic solutions remains steadfast, and we will continue to add innovative products and services to our portfolio to meet the ever-changing needs of our customers.

Related posts

No items found.